ESWT versus conventional physical therapy for Greater Trochanteric Pain Syndrome
Official title: A Prospective Randomized Controlled Trial Comparing the Effectiveness of Extracorporeal Shockwave Therapy and Conventional Physical Therapy in Patients With Greater Trochanteric Pain Syndrome
Run by Kanuni Sultan Suleyman Training and Research Hospital · NCT07243327 · Data updated 2026-11-12
This trial will try Extracorporeal Shockwave Therapy (ESWT) against usual physical therapy to see which reduces pain and improves function in adults with Greater Trochanteric Pain Syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Kanuni Sultan Suleyman Training and Research Hospital Academic / other |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | March 2026 |
| Study ends | March 2026 |
| Registry record updated | January 27, 2026 |
| Trial ID | NCT07243327 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 with lateral hip pain for at least 3 months and MRI-confirmed GTPS who can attend clinic visits and follow the exercise program are ideal candidates.
✕Probably not a fit
Patients with hip tendon tears, recent hip infection or trauma, lumbar radiculopathy or prior lumbar surgery, recent corticosteroid injection to the hip, active systemic inflammatory disease, active malignancy, or cognitive impairment are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial will enroll 60 adults aged 18–65 with MRI-confirmed Greater Trochanteric Pain Syndrome and allocate them 1:1 to ESWT or conventional physical therapy. The ESWT arm receives five sessions over three weeks (15 Hz, 3 bar, 2000 pulses) while the physical therapy arm receives ten sessions of TENS, hot pack, and continuous ultrasound; both groups follow a standardized exercise program. Outcomes include pain (VAS), hip function (Harris Hip Score), lower extremity function (LEFS), and a Global Rating of Change measured at baseline, week 3, and week 12. The primary aim is to see which treatment produces greater short-term pain relief, with secondary analyses of functional improvement.
Why it matters
Potential benefit: If successful, ESWT could provide faster or greater pain relief and improved hip function than conventional physical therapy for people with GTPS.
How similar studies have gone: Previous randomized trials and case series of ESWT for gluteal tendinopathy have generally shown favorable outcomes compared with sham or conservative care, though results have varied across studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 65 years * Lateral hip pain for at least 3 months * Ability to understand study procedures and provide informed consent Exclusion Criteria: * Hip deformities * Gluteus medius, gluteus minimus, or piriformis tendon tears * Lumbar radiculopathy or history of lumbar spine surgery * Recent trauma or active infection in the hip region * Corticosteroid injection to the hip within the last 6 months * Neurological, psychiatric, or rheumatologic diseases * Active malignancy or systemic inflammatory disease * Cognitive impairment preventing cooperation
Where it's running
-
Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Zeynep Karakuzu Güngör — Kanuni Sultan Suleyman Training and Research Hospital
- Study coordinator: Zeynep Karakuzu Güngör, M.D
- Email: zeynepkarakuzu@hotmail.com.tr
- Phone: +90 507 775 03 75
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High-Intensity Laser Therapy for Greater Trochanteric Pain Syndrome
This trial tests whether high-intensity laser therapy can reduce pain and improve function for adults with GTPS compared with a sham treatment.
-
ReneuRx for lateral hip pain: a treatment option for people with GTPS
This study tests whether the ReneuRx device can relieve moderate to severe lateral hip pain in adults compared with a corticosteroid injection.
-
Exercise and education program for lateral hip pain
This study is testing whether a special exercise program and education can help people with lateral hip pain feel better after 12 weeks of treatment.
-
Evaluating TENEX for hip pain relief
This study is testing if a special ultrasound-guided procedure called TENEX can help people with chronic hip pain feel better and move easier when other treatments haven't worked.
-
Improve how people with GTPS do their hip exercises by timing and reminders
This study tests a timing-based approach, with or without reminders, to help adults with GTPS stick to a hip exercise program.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.